News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Marillion Pharmaceuticals and Bracco Imaging S.p.A. Announce License Agreement to Develop and Commercialize Novel Cancer Treatment



11/11/2008 9:27:16 AM

MALVERN, Pa. & PRINCETON, N.J.--(BUSINESS WIRE)--Marillion Pharmaceuticals Inc. and Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business and part of the Bracco Group, announced today that the two companies have entered into a license agreement granting Marillion exclusive worldwide rights to complete clinical development and to commercialize Bracco’s 177Lu-AMBA for the treatment of hormone-resistant prostate and advanced (metastatic) breast cancers.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES